Virbac S.A.
VIRP
Pozycja w akcjach
#4649
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Cena akcji
$388.56
Ostatnia synchronizacja: 2026-10-21
Kapitalizacja rynkowa
$3.26B
Zmiana (1 dzień)
-5.05%
Zmiana (1 rok)
-6.40%
Kraj
FR
Handel Virbac S.A. (VIRP)
Kategoria
Healthcare
Przychody dla Virbac S.A. (VIRP)
Przychody w Jun 2026 TTM: $1.77B
Według najnowszych raportów finansowych Virbac S.A., obecny przychód firmy (TTM) wynosi $1.77B. W roku 2023 firma osiągnęła przychód w wysokości $1.38B wzrost w porównaniu do przychodu z roku 2022, który wynosił $1.30B. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Virbac S.A. od 2002 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $1.77B | 21.90% |
| 2024 | $1.45B | 5.49% |
| 2023 | $1.38B | 5.66% |
| 2022 | $1.30B | 7.83% |
| 2021 | $1.21B | 6.34% |
| 2020 | $1.14B | 8.07% |
| 2019 | $1.05B | 5.44% |
| 2018 | $998.54M | -3.45% |
| 2017 | $1.03B | 12.74% |
| 2016 | $917.32M | -0.92% |
| 2015 | $925.80M | -1.03% |
| 2014 | $935.43M | -7.59% |
| 2013 | $1.01B | 10.39% |
| 2012 | $916.98M | 13.69% |
| 2011 | $806.57M | 5.31% |
| 2010 | $765.86M | 14.27% |
| 2009 | $670.22M | 8.47% |
| 2008 | $617.87M | -3.61% |
| 2007 | $641.03M | 21.30% |
| 2006 | $528.47M | 20.10% |
| 2005 | $440.02M | -7.65% |
| 2004 | $476.49M | 6.66% |
| 2003 | $446.73M | 15.70% |
| 2002 | $386.10M | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| $79.67B | 4,394.46% |
US
|
|
| $99.34B | 5,504.13% |
US
|
|
| $64.39B | 3,532.43% |
US
|
|
| $66.40B | 3,646.05% |
US
|
|
| $77.52B | 4,273.32% |
CH
|
